Lorlagen (Lorlatinib), generic Lorbrena is a prescription medicine that is used to treat metastatic non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Lorlatinib is used in patients who have already received alectinib, ceritinib, or both crizotinib and at least 1 other medicine to treat NSCLC that is caused by the ALK gene. Lorlagen is manufactured by General Pharmaceuticals Ltd. in Bangladesh.
Lorlagen 100 mg (Lorlatinib)
Categories Anti-Cancer, Lung Cancer, Oncology Medicine
Tags General Pharmaceuticals Ltd, Loralagen, Lorlagen 100 mg, Lorlatinib
Related products
- Anti-Cancer
Xevirol 5 mg (Everolimus)
- hepatitis C virus
Sofosvel 400 mg (Sofosbuvir & Velpatasvir)
- Oncology Medicine
Hernix 40 mg (Neratinib)
- Anti-Cancer
Crizonix 250 mg (Crizotinib)
- Anti-Cancer
Cabozanix 20 mg (Cabozantinib)
- Anti-Cancer
Baricinix 2 mg (Baricitinib)